Companies: 10,795·Total market cap: $144.5T
Innoviva, Inc.

Innoviva, Inc.

INVANASDAQHealthcare● Active
$22.34
$-0.18(-0.80%)
Market Cap$1.6B
P/E Ratio
52W High$25.15
52W Low$16.52

Innoviva, Inc.(INVA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · INVA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.43B$0.36B$0.31B$0.33B$0.39B
Cost of Revenue$0.12B$0.04B$0.04B$0.01B$0.00B
Gross Profit$0.31B$0.32B$0.27B$0.32B$0.39B
Gross Margin %(computed)72.33%89.80%86.27%95.84%100.00%
Operating Expenses
R&D Expenses$0.03B$0.01B$0.03B$0.04B$0.00B
G&A Expenses$0.00B$0.00B$0.00B$0.06B$0.02B
Total Operating Expenses$0.14B$0.16B$0.15B$0.11B$0.02B
Operating Income$0.16B$0.17B$0.11B$0.21B$0.38B
Operating Margin %(computed)38.52%46.52%36.68%62.47%95.72%
Interest Income$0.02B$0.02B$0.02B$0.01B$0.00B
Interest Expense$0.02B$0.02B$0.02B$0.02B$0.02B
Income Before Tax$0.33B$0.04B$0.19B$0.29B$0.45B
Income Tax Expense$0.06B$0.01B$0.01B$0.07B$0.08B
Net Income$0.27B$0.02B$0.18B$0.21B$0.27B
Net Margin %(computed)63.78%6.52%57.89%64.56%67.84%
Per Share & EBITDA
EPS (Basic)$4.02$0.37$2.92$3.07$3.24
Wtd Avg Shares0.07B0.06B0.07B0.07B0.08B
EBITDA$0.38B$0.09B$0.24B$0.31B$0.46B
EBITDA Margin %(computed)90.28%23.84%75.71%93.05%118.50%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Innoviva, Inc.

关于Innoviva, Inc.(INVA)损益表

Innoviva, Inc.(INVA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,INVA实现营收$0.43B,毛利润$0.31B(毛利率72.33%),净利润$0.27B(净利率63.78%)。

常见问题

INVA · 4 问

Innoviva, Inc.(INVA)2025财年营收为$0.43B,同比up18.5%。

INVA revenueINVA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08